Description
This study aims to find out the effectiveness of a new medication to potentially treat COPD. The research study has been reviewed and approved by the Copernicus Group Institutional Review Board (CGIRB)
Men and women aged 40 to 85 years old who have been diagnosed with Chronic Obstructive Pulmonary Disorder (COPD) can join.
Why Participate?
Participants will receive all study-related medical care at no cost.
Participants will be seen by a doctor who will closely watch their COPD.
Participants will be compensated for their participation in this study.
Participants will be helping to advance medical, specifically COPD treatment, research.
Learn More:
Discussion
By posting you agree to the Terms and Privacy Policy.